Claims for Patent: 10,172,987

Summary for Patent: 10,172,987

Title:	System and method for heart pump interrogation and inspection
Abstract:	The present invention relates to systems and methods for in situ inspection, interrogation, and maintenance of heart pump function in subjects with an implanted heart pump. In certain embodiments, the system comprises a catheter assembly deliverable to the inflow port and outflow port of the implanted heart pump. The system comprises additional components used to examine pump function and prevent malfunction. In certain embodiments, the invention allows for temporary, mid-term, or permanent exclusion of the implanted heart pump from cardiac function without surgically removing the pump.
Inventor(s):	Bonde; Pramod (Woodbridge, CT)
Assignee:	YALE UNIVERSITY (New Haven, CT)
Application Number:	14/276,346
Patent Claims:	1. A method for in situ inspection of an implanted heart pump comprising at least one inflow port, at least one outflow port and an interior chamber therebetween, the interior chamber including at least one mechanical component of the heart pump, the method comprising: guiding a catheter into the inflow port or outflow port of a heart pump implanted in a subject; and advancing a device component through an inner lumen of the catheter and into the interior chamber. 2. The method of claim 1, wherein the method comprises delivering a scope through an inner lumen of the catheter into an interior chamber of the heart pump to allow for visual inspection of the interior of the heart pump. 3. The method of claim 1, wherein the method comprises inflating a balloon positioned at the distal end of the catheter, thereby occluding blood flow. 4. A method for reducing the presence of blood clots within an implanted heart pump comprising at least one inflow port, at least one outflow port and an interior chamber therebetween, the interior chamber including at least one mechanical component of the heart pump, the method comprising: guiding a first catheter to the inflow port of a heart pump implanted in a subject; guiding a fluid delivery device through an inner lumen of the first catheter into the interior chamber of the heart pump; and administering a fluid to the interior of the heart pump, wherein the fluid reduces the presence of blood clots within the heart pump. 5. The method of claim 4, wherein the fluid delivery device is guided to the heart pump via the working channel of a scope, wherein the scope is guided to the heart pump via the inner lumen of the first catheter. 6. The method of claim 4, wherein the fluid comprises an anticoagulant selected from the group consisting of heparin, tissue plasminogen activator (tPa), streptokinase, collagenase, proteases, proteoltyic agents, superhydrophobic agents, and analogs thereof. 7. A method for in situ inspection of an implanted heart pump and excluding the heart pump from the blood flow circuit of a subject having the implanted heart pump, the heart pump comprising at least one inflow port, at least one outflow port and an interior chamber therebetween, the interior chamber including at least one mechanical component of the heart pump, the method comprising: guiding a first catheter to the inflow port of the heart pump; guiding a second catheter to the outflow port of the heart pump; occluding flow into the heart pump by positioning a first occlusion structure at the inflow port; occluding flow out of the heart pump by positioning a second occlusion structure at the outflow port; and advancing a device component through an inner lumen at least one of the first and second occlusion structure and into the interior chamber. 8. The method of claim 7, wherein the first and second occlusion structures each comprise an inflated balloon. 9. The method of claim 7, further comprising assessing the cardiac function of native heart tissue while the heart pump is excluded from the blood flow circuit. 10. The method of claim 7, wherein the first and second occlusion structures each comprise a closure device guided to the inflow port and outflow port via the first and second catheter. 11. The method of claim 10, wherein the closure device is manufactured from a material selected from the group consisting of titanium, stainless steel, nitinol, polyethylene terephthalate, polyether ether ketone, polyurethane, and graphene.

Details for Patent 10,172,987

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2033-05-13